Nurse Stole Fentanyl from Fertility Clinic, Leaving Patients in Agony

Between June and October 2020, registered nurse Donna Monticone stole fentanyl intended for patients at Yale University's fertility clinic in Orange, Connecticut, and replaced it with saline. Approximately 75% of the painkiller given during this period had been tampered with, leaving at least 93 women in excruciating pain during invasive procedures.

Monticone, who worked at the Yale University Reproductive Endocrinology and Infertility clinic, was feeding an opioid addiction by diverting the powerful painkiller meant to sedate patients undergoing egg-retrieval and in-vitro fertilization (IVF) procedures. Instead of receiving fentanyl for pain control, patients received only saline—a sterile saltwater solution with no analgesic properties.

The scope of the tampering was staggering. Prosecutors determined that around 75% of fentanyl administered to patients at the clinic over those five months had been adulterated. Hundreds of women may have unknowingly been treated with saline instead of fentanyl, though exact figures vary across reports.

Patients reported suffering intense, uncontrolled pain during and after procedures—experiences they described as traumatic. According to lawsuits filed by affected women, their complaints of extreme pain were dismissed or minimized by clinic staff, adding psychological injury to their physical suffering.

Investigations into the clinic's operations revealed serious safety failures. Lawsuits alleged that Yale kept more than 175 vials of fentanyl in an unsupervised, unlocked area, creating an environment where drug diversion could occur. The university had failed to implement basic safeguards such as regular drug testing for staff with access to controlled substances, and pharmacy protocols were not properly enforced.

Monticone was ultimately convicted of tampering with patients' fentanyl and related drug-diversion crimes. During her sentencing hearing, she apologized to her victims—a gesture that did little to undo the harm inflicted on women who had sought medical help to build their families.

The civil consequences followed. In September 2024, dozens of women reached a settlement with Yale University over their lawsuit alleging that the institution had allowed the fentanyl tampering to occur and failed in its duty to protect patients. While the terms of the settlement were not publicly disclosed, lawyers representing the plaintiffs described the financial compensation as significant.

The case raises troubling questions about oversight in medical settings. Egg-retrieval and IVF procedures are invasive treatments that require adequate sedation—not as a comfort measure, but as a medical necessity. When patients received saline instead, they experienced what amounted to surgery without proper anesthesia. The dismissal of their pain complaints compounded the harm, suggesting a culture in which patient safety concerns were not taken seriously.

For the affected women, the settlements and convictions represent some measure of accountability. Yet the case underscores how vulnerable patients can be when institutions prioritize cost-cutting or operational convenience over rigorous drug-handling procedures and staff monitoring. The unsupervised fentanyl storage, lack of inventory controls, and absence of drug testing for staff all represent preventable failures.

This incident serves as a stark reminder that safeguards protecting controlled substances must be taken seriously—especially in settings where patients are unable to advocate for themselves during medical procedures. The women who passed through Yale's fertility clinic expected care and pain relief. Instead, they received betrayal and agony.

Sources

https://www.latimes.com/world-nation/story/2024-09-09/women-settle-lawsuits-after-yale-fertility-nurse-switched-painkiller-for-saline

https://abcnews.go.com/wellness/story/women-pain-dismissed-lawsuit-alleging-fentanyl-switch-fertility/?id=81252153